Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasia characterized by the BCR::ABL1 fusion gene, which codifies the BCR-ABL protein with increased tyrosine kinase activity. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.